BARCLAYS PLC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 124 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25
-55.4%
16,733
-52.7%
0.00%
Q2 2023$56
-95.2%
35,353
-91.2%
0.00%
-100.0%
Q1 2023$1,162
+23.4%
400,563
+39.4%
0.00%
Q4 2022$942
-99.9%
287,426
-16.8%
0.00%
-100.0%
Q3 2022$1,306,000
+677.4%
345,613
+1500.1%
0.00%
Q2 2022$168,000
-75.6%
21,600
-70.9%
0.00%
-100.0%
Q1 2022$688,000
-90.6%
74,145
-84.1%
0.00%0.0%
Q4 2021$7,350,000
+35.4%
466,384
+53.8%
0.00%
-50.0%
Q3 2021$5,427,000
+13.4%
303,183
-1.5%
0.00%0.0%
Q2 2021$4,787,000
+83.6%
307,868
+69.5%
0.00%
+100.0%
Q1 2021$2,608,000
+91.1%
181,621
+161.1%
0.00%0.0%
Q4 2020$1,365,000
+31.9%
69,573
-12.9%
0.00%0.0%
Q3 2020$1,035,000
-33.1%
79,886
-24.8%
0.00%0.0%
Q2 2020$1,548,000
+126.6%
106,239
+32.1%
0.00%0.0%
Q1 2020$683,000
-37.1%
80,419
+22.1%
0.00%0.0%
Q4 2019$1,085,000
+106.3%
65,884
+76.7%
0.00%
Q3 2019$526,000
-69.8%
37,284
-57.0%
0.00%
-100.0%
Q2 2019$1,744,000
+207.6%
86,686
+507.2%
0.00%
Q1 2019$567,000
-60.5%
14,276
-65.5%
0.00%
-100.0%
Q4 2018$1,436,000
+113.1%
41,320
+153.6%
0.00%
Q3 2018$674,000
-85.6%
16,293
-87.2%
0.00%
-100.0%
Q2 2018$4,668,000
+1293.4%
126,978
+1376.8%
0.00%
Q1 2018$335,000
+112.0%
8,598
-1.0%
0.00%
Q4 2017$158,000
-40.2%
8,687
-45.5%
0.00%
Q3 2017$264,000
-78.3%
15,932
-81.6%
0.00%
-100.0%
Q2 2017$1,215,000
+542.9%
86,800
+846.6%
0.00%
Q1 2017$189,000
+56.2%
9,170
+5.8%
0.00%
Q4 2016$121,000
+1412.5%
8,670
+2181.6%
0.00%
Q3 2016$8,000
-92.6%
380
-92.1%
0.00%
Q2 2016$108,000
+2600.0%
4,803
+2266.0%
0.00%
Q1 2016$4,000
-77.8%
203
-70.5%
0.00%
Q4 2015$18,000
+200.0%
688
+247.5%
0.00%
Q3 2015$6,000
-57.1%
198
-28.8%
0.00%
Q2 2015$14,000
+75.0%
278
+33.0%
0.00%
Q1 2015$8,000
-33.3%
209
-55.2%
0.00%
Q4 2014$12,0004670.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
KPCB XV Associates, LLC 1,876,650$29,576,00023.33%
Antipodean Advisors LLC 1,000,000$15,760,0006.47%
M28 Capital Management LP 456,865$7,200,0005.62%
Redmile Group, LLC 6,437,777$101,459,0002.31%
One Fin Capital Management LP 303,000$4,775,0001.99%
MAVERICK CAPITAL LTD 7,855,824$123,808,0001.40%
Baupost Group 8,477,488$133,605,0001.32%
BRIDGER MANAGEMENT, LLC 616,488$9,716,0001.26%
683 Capital Management, LLC 1,781,234$28,073,0001.03%
Trellus Management Company, LLC 95,000$1,497,0001.00%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders